Elicio Therapeutics
PublicElicio Therapeutics is now publicly traded
The data on this page reflects Elicio Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Dec 22, 2023
Total Funding Raised
$38.92M
Company Overview
Elicio Therapeutics operates in Healthcare and is based in Boston, Massachusetts. It has raised $38.92M.
Elicio Therapeutics is a biotechnology company that develops innovative cancer immunotherapies using its proprietary Amphiphile (AMP) platform to target lymph nodes.
Sector
Healthcare
AI Layer
Non-AI
Elicio Therapeutics Comparables
Compare Elicio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nouscom | 76% | |
| Immunomic Therapeutics | 76% | |
| Treme Bio | 73% |
For institutional investors. Book with your work email.
Elicio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Dec 22, 2023 | ||||
| Private Placement | Jun 12, 2020 | ||||
| Private Placement | Jul 5, 2018 | ||||
| Private Placement | Jan 11, 2017 | ||||
| Private Placement | Jan 7, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elicio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.